These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 8516315

  • 1. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
    Rothman DL, Petroff OA, Behar KL, Mattson RH.
    Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5662-6. PubMed ID: 8516315
    [Abstract] [Full Text] [Related]

  • 2. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
    Petroff OA, Rothman DL, Behar KL, Mattson RH.
    Epilepsia; 1995 May 15; 36(5):457-64. PubMed ID: 7614922
    [Abstract] [Full Text] [Related]

  • 3. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG, Weber OM, Duc CO, Weber B, Meier D, Russ W, Boesiger P, Wieser HG.
    Epilepsia; 2001 Jan 15; 42(1):29-40. PubMed ID: 11207782
    [Abstract] [Full Text] [Related]

  • 4. Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo.
    Hyder F, Petroff OA, Mattson RH, Rothman DL.
    Magn Reson Med; 1999 May 15; 41(5):889-96. PubMed ID: 10332870
    [Abstract] [Full Text] [Related]

  • 5. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
    Petroff OA, Rothman DL, Behar KL, Mattson RH.
    Neurology; 1996 May 15; 46(5):1459-63. PubMed ID: 8628502
    [Abstract] [Full Text] [Related]

  • 6. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
    Petroff OA, Behar KL, Mattson RH, Rothman DL.
    J Neurochem; 1996 Dec 15; 67(6):2399-404. PubMed ID: 8931472
    [Abstract] [Full Text] [Related]

  • 7. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
    Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH.
    Neurology; 1996 Dec 15; 47(6):1567-71. PubMed ID: 8960747
    [Abstract] [Full Text] [Related]

  • 8. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
    Petroff OA, Rothman DL.
    Mol Neurobiol; 1998 Feb 15; 16(1):97-121. PubMed ID: 9554704
    [Abstract] [Full Text] [Related]

  • 9. The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA).
    Manor D, Rothman DL, Mason GF, Hyder F, Petroff OA, Behar KL.
    Neurochem Res; 1996 Sep 15; 21(9):1031-41. PubMed ID: 8897466
    [Abstract] [Full Text] [Related]

  • 10. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA, Hyder F, Collins T, Mattson RH, Rothman DL.
    Epilepsia; 1999 Jul 15; 40(7):958-64. PubMed ID: 10403220
    [Abstract] [Full Text] [Related]

  • 11. Gamma-vinyl GABA: a new antiepileptic drug.
    Hammond EJ, Wilder BJ.
    Clin Neuropharmacol; 1985 Jul 15; 8(1):1-12. PubMed ID: 3884148
    [No Abstract] [Full Text] [Related]

  • 12. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
    Mattson RH, Petroff O, Rothman D, Behar K.
    Epilepsia; 1994 Jul 15; 35 Suppl 5():S29-32. PubMed ID: 8039467
    [Abstract] [Full Text] [Related]

  • 13. GABA changes with vigabatrin in the developing human brain.
    Novotny EJ, Hyder F, Shevell M, Rothman DL.
    Epilepsia; 1999 Apr 15; 40(4):462-6. PubMed ID: 10219272
    [Abstract] [Full Text] [Related]

  • 14. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA, Mattson RH, Behar KL, Hyder F, Rothman DL.
    Ann Neurol; 1998 Dec 15; 44(6):948-52. PubMed ID: 9851440
    [Abstract] [Full Text] [Related]

  • 15. Nuclear magnetic resonance detection of increased cortical GABA in vigabatrin-treated rats in vivo.
    Preece NE, Jackson GD, Houseman JA, Duncan JS, Williams SR.
    Epilepsia; 1994 Dec 15; 35(2):431-6. PubMed ID: 8156969
    [Abstract] [Full Text] [Related]

  • 16. Brain GABA editing by localized in vivo (1)H magnetic resonance spectroscopy.
    Bielicki G, Chassain C, Renou JP, Farges MC, Vasson MP, Eschalier A, Durif F.
    NMR Biomed; 2004 Apr 15; 17(2):60-8. PubMed ID: 15052553
    [Abstract] [Full Text] [Related]

  • 17. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R, Herranz JL, Valdizán EM, Armijo JA.
    Epilepsia; 1992 Apr 15; 33(5):923-31. PubMed ID: 1396437
    [Abstract] [Full Text] [Related]

  • 18. GABA in epilepsy: the pharmacologic basis.
    Gale K.
    Epilepsia; 1989 Apr 15; 30 Suppl 3():S1-11. PubMed ID: 2548836
    [Abstract] [Full Text] [Related]

  • 19. gamma-vinyl GABA, and GABA and beta-alanine transamination.
    Lancet; 1984 Mar 31; 1(8379):737-8. PubMed ID: 6143066
    [No Abstract] [Full Text] [Related]

  • 20. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy.
    Petroff OA, Hyder F, Mattson RH, Rothman DL.
    Neurology; 1999 Feb 31; 52(3):473-8. PubMed ID: 10025774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.